Portfolio company
Oncocine
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops an artificial intelligence platform to design mRNA cancer vaccines for pharmaceutical and biotechnology organisations.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Genevation
This biotechnology company develops personalised mRNA cancer vaccines and therapeutics using artificial intelligence for patients requiring precision oncology treatments.
myNEO Therapeutics
This company develops AI-driven cancer vaccines and immunotherapy targets from the dark genome for biopharmaceutical partners and clinical applications.
AilseBio
This biotech company develops artificial intelligence to discover therapy-induced antigens for cancer vaccines and immunotherapies for the healthcare sector.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Inceptive Nucleics
This company develops artificial intelligence models to design novel RNA-based medicines and biotechnologies for pharmaceutical and biotechnology partners.
Baseimmune
The company develops AI-designed vaccines and antigens for pharmaceutical partners and biotech researchers to treat infectious diseases and chronic conditions in humans and animals.
Kerna Labs
This company develops artificial intelligence models to design and optimise synthetic messenger RNA sequences for pharmaceutical and biotechnology researchers.
